Recommended videos you might also like
15:26
Chest Pain in Aortic Stenosis: Novel Diagnostic and therapeutic Data - Dennis...
16:21
Refractory Hypertension: What is Essential to Know in 2017 - Thomas Kahan
11:04
Terminology – iFR, FFR, CFR, HSR what do all the abbreviations mean?
14:47
Clinical Data with PCSK9 inhibitors - Alberto Lorenzatti
31:14
Discussion of ISCP 2017 - Prevention and Treatment of atherosclerosis
11:47
Myocardial infarction and Non-Obstructive Coronary Arteries - Stefan Agewall
Video Player is loading.
Ranolazine - Pharmacological Characteristics and therapeutic Effects - Juan Tamargo
93 views
Summary
Ranolazine - Pharmacological Characteristics and therapeutic Effects - Presented by Juan Tamargo at ISCP 2017.
Simple Education
1,191 videos
Simple Education, is a leading provider of coronary physiology and intracoronary imaging courses to aid treatment of complex coronary artery disease.
Speakers
Juan Tamargo
Speaker
Works at Universidad Complutense, Madrid, Spain. Features in 1 video on Wondr Medical. Juan... Works at Universidad Complutense, Madrid, Spain. Features in 1 video on Wondr Medical. Juan Tamargo generally speaks on Aorta, Coronary arteries, PCSK9 Antagonists, and Anti-Platelet Drugs .
Join the conversation
to comment
Related videos
Simple Education
Novel Lipid Lowering Therapy Against Coronary atherosclerosis: Role of PCSK9 Inhibitors - Masayuki Yoshida
Simple Education
Discussion of ISCP 2017 - Coronary Artery Disease - Joint Session ISCP and European Association of Professors Emeriti
Simple Education
